Global Orthopedic Oncology Treatment Market is Expected to Grow at 2.5% by 2030
Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which include trauma, spine, hand, and upper extremity, total joints and even pediatric orthopedics.
Sometimes tumors or tumor-like conditions show up in the bone and soft tissue of the musculoskeletal system this condition is called bone cancer. A medical specialty concerned with the diagnosis and treatment of benign and malignant tumors of bone and soft tissues. These tumors include Ewing sarcoma, osteosarcoma, and other malignancies that involve the musculoskeletal system. Orthopedic oncology represents only a small percentage of the field of orthopedics. Even when benign tumors of the musculoskeletal system are included, the incidence of these conditions pales in comparison to trauma, spine, hand and upper extremity, total joints, and even pediatric orthopedics. However, orthopedic oncology continues to be invigorated by exciting developments and research that has advanced the care of patients with various bone and soft-tissue tumors. Additional advances have come in the field of imaging. Computer tomography (CT) is used to identify pulmonary metastasis, which can be treated with chemotherapy and/or resection with potential cure in many cases. Magnetic resonance imaging (MRI) better defines local extent of disease and skip metastases to allow accurate definitive surgery and early detection of local recurrence. Finally, positron emission tomography (PET) is proving to be valuable in the detection of local recurrence and may be a valuable predictor of response to chemotherapy in bone and soft tissue malignancies.
Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to the fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which include trauma, spine, hand, and upper extremity, total joints and even pediatric orthopedics. However, the field of orthopedic oncology continues to be invigorated by exhilarating research and developments that have enhanced the level of treatment and care of patients with various bone and soft-tissue tumors. Currently, most patients with primary bone sarcomas are offered limb salvage surgery without increasing the risk of survival at the sarcoma centers. Moreover, the advances in imaging techniques and surgical techniques have further improved the treatment of patients with bone and soft-tissue malignancies. Orthopedic oncologists continue to collaborate with other subspecialists to integrate advances in surgical techniques. This is especially true for the development of implants and image-guided surgery.
The global orthopedic oncology treatment market on type of procedures has been segmented into soft tissue excisions/resections, limb salvage surgery, amputation, adjuvant chemotherapy, and reconstructive surgery. The reconstructive surgery is further sub-segmented into hip & joint replacement and bone grafts.
Dominating Segment is Reconstructive surgery
Reconstructive surgery has the largest share in the global orthopedic oncology treatment market. The bone grafting techniques are anticipated to grow at the highest rate during the forecast period owing to the advances in the field of prosthesis and endoprosthesis.
Latin America, the Middle East, and Africa have emerged as the most potential market
In base 2020, Asia Pacific was observed as the largest market for orthopedic oncology market. Large disease prevalence along with the growing healthcare ecosystem in the region has assisted the growth of the orthopedic oncology market in Asia-Pacific. Moreover, growth in medical tourism in the region in the last decade has further fueled the market for orthopedic oncology treatment market in Asia-Pacific. Latin America, the Middle East, and Africa have emerged as the most potential market due to the high prevalence of osteosarcoma and lower treatment options available in the region. Hence, this market would exhibit a strong growth rate during the forecast period with the development of the healthcare infrastructure.
Historical & Forecast Period
This report represents an analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations, and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Orthopedic Oncology Treatment market are as follows:
- Research and development budgets of manufacturers and government spending.
- Revenues of key companies in the market segment.
- Number of end users and consumption volume, price, and value.
- Geographical revenues generated by countries considered in the report.
- Micro and macro environment factors that are currently influencing the Orthopedic Oncology Treatment market and their expected impact during the forecast period.
- The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Type of Procedure
- Soft Tissue Excisions/Resections
- Limb Salvage Surgery
- Amputation
- Adjuvant Chemotherapy
- Reconstructive Surgery
- Hip & Joint Replacement
- Bone Grafts
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Orthopedic Oncology Treatment market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Orthopedic Oncology Treatment market?
- Which is the largest regional market for Orthopedic Oncology Treatment market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Orthopedic Oncology Treatment market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Orthopedic Oncology Treatment market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Orthopedic Oncology Treatment Market
2.2. Global Orthopedic Oncology Treatment Market, by Type of Procedure, 2021 (US$ Million)
2.3. Global Orthopedic Oncology Treatment Market, by Geography, 2021 (US$ Million)
2.4. Impact of COVID-19
2.5. Attractive Investment Proposition by Geography, 2021
2.6. Competitive Analysis
2.6.1. Market Positioning of Key Orthopedic Oncology Treatment Market Vendors
2.6.2. Strategies Adopted by Orthopedic Oncology Treatment Market Vendors
2.6.3. Key Industry Strategies
3. Orthopedic Oncology Treatment Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Orthopedic Oncology Treatment Market Value, 2020-2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat of Substitutes
3.6.4. Threat of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
4. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Soft Tissue Excisions/Resections
4.3.2. Limb Salvage Surgery
4.3.3. Amputation
4.3.4. Adjuvant Chemotherapy
4.3.5. Reconstructive Surgery
4.3.5.1. Hip & Joint Replacement
4.3.5.2. Bone Grafts
5. North America Orthopedic Oncology Treatment Market, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
5.3. Orthopedic Oncology Treatment Market: by Region, 2020-2030, USD (Million)
5.3.1. North America
5.3.1.1. U.S.
5.3.1.2. Canada
5.3.1.3. Rest of North America
6. UK and European Union Orthopedic Oncology Treatment Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
6.3. Orthopedic Oncology Treatment Market: by Region, 2020-2030, USD (Million)
6.3.1. UK and European Union
6.3.1.1. UK
6.3.1.2. Germany
6.3.1.3. Spain
6.3.1.4. Italy
6.3.1.5. France
6.3.1.6. Rest of Europe
7. Asia Pacific Orthopedic Oncology Treatment Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
7.3. Orthopedic Oncology Treatment Market: by Region, 2020-2030, USD (Million)
7.3.1. Asia Pacific
7.3.1.1. China
7.3.1.2. Japan
7.3.1.3. India
7.3.1.4. Australia
7.3.1.5. South Korea
7.3.1.6. Rest of Asia Pacific
8. Latin America Orthopedic Oncology Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
8.3. Orthopedic Oncology Treatment Market: by Region, 2020-2030, USD (Million)
8.3.1. Latin America
8.3.1.1. Brazil
8.3.1.2. Mexico
8.3.1.3. Rest of Latin America
9. Middle East and Africa Orthopedic Oncology Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Orthopedic Oncology Treatment Market: by Type of Procedure, 2020-2030, USD (Million)
9.3. Orthopedic Oncology Treatment Market: by Region, 2020-2030, USD (Million)
9.3.1. Middle East and Africa
9.3.1.1. GCC
9.3.1.2. Africa
9.3.1.3. Rest of Middle East and Africa
10. Company Profiles
10.1. Stryker Corporation
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Portfolio
10.1.4. Strategic Initiatives
10.2. Zimmer Biomet Holdings, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Portfolio
10.2.4. Strategic Initiatives
10.3. Smith & Nephew plc
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Portfolio
10.3.4. Strategic Initiatives
10.4. DePuy Synthes (Johnson & Johnson)
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Portfolio
10.4.4. Strategic Initiatives
10.5. Medtronic
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Portfolio
10.5.4. Strategic Initiatives
10.6. Accentus Medical
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Portfolio
10.6.4. Strategic Initiatives
10.7. Roche Holding AG
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Portfolio
10.7.4. Strategic Initiatives
10.8. Amgen, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Portfolio
10.8.4. Strategic Initiatives
10.9. Novartis AG
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Portfolio
10.9.4. Strategic Initiatives
10.10. GlaxoSmithKline
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Portfolio
10.10.4. Strategic Initiatives
10.11. Sanofi
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Portfolio
10.11.4. Strategic Initiatives
10.12. Pfizer Inc.
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Portfolio
10.12.4. Strategic InitiativesList of Figures
Figure 1. Global Orthopedic Oncology Treatment Market: Market Coverage
Figure 2. Research Methodology and Data Sources
Figure 3. Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4. Global Orthopedic Oncology Treatment Market: Quality Assurance
Figure 5. Global Orthopedic Oncology Treatment Market, By Type of Procedure, 2021
Figure 6. Global Orthopedic Oncology Treatment Market, By Geography, 2021
Figure 7. Global Orthopedic Oncology Treatment Market, By Type of Procedure, 2021 vs 2030, %
Figure 8. U.S. Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 9. Canada Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 10. Rest of North America Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 11. UK Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 12. Germany Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 13. Spain Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 14. Italy Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 15. France Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 16. Rest of Europe Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 17. China Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 18. Japan Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 19. India Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 20. Australia Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 21. South Korea Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 22. Rest of Asia Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 23. Brazil Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 24. Mexico Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 25. Rest of Latin America Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 26. GCC Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 27. Africa Orthopedic Oncology Treatment Market (US$ Million), 2020-2030
Figure 28. Rest of Middle East and Africa Orthopedic Oncology Treatment Market (US$ Million), 2020-2030List of Tables
Table 1 Global Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 2 Global Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Table 3 North America Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 4 North America Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Table 5 UK and European Union Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 6 UK and European Union Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Table 7 Asia Pacific Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 8 Asia Pacific Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Table 9 Latin America Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 10 Latin America Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Table 11 Middle East and Africa Orthopedic Oncology Treatment Market by Type of Procedure, 2020-2030, USD (Million)
Table 12 Middle East and Africa Orthopedic Oncology Treatment Market by Reconstructive Surgery, 2020-2030, USD (Million)
Companies Mentioned
- Stryker Corporation
- Zimmer Biomet Holdings Ltd.
- Smith & Nephew PLC
- DePuy Synthes (Johnson & Johnson)
- Medtronic
- Accentus Medical
- Roche Holding AG
- Amgen Ltd.
- Novartis AG
- GlaxoSmithKline
- Sanofi
- Pfizer Inc.
